Comparison: Compounded Semaglutide vs Wegovy
Both are reviewed at American Telehealth Review against published clinical evidence and FDA labeling.
Key differentiators
- Active ingredient: same (semaglutide), different supply chain.
- FDA status: Wegovy is FDA-approved; compounded is not.
- Pharmacy: Wegovy is made by Novo Nordisk in FDA-inspected facilities; compounded semaglutide usually comes from state-licensed 503A pharmacies (USP <797>).
- Price: Wegovy $349/mo (NovoCare self-pay, read October 15, 2026) cash; compounded $119-From $179/mo (read October 15, 2026).
- Quality flag: only semaglutide base — no salt forms (sodium/acetate).